autologous blood

Cell therapyexperimental

Autotransplantation is the transplantation of organs, tissues, or even particular proteins from one part of the body to another in the same person. — Wikipedia

Clinical trial activity

18 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
4
Phase 3
2
Phase 4
1

Earliest trial started Jan 1, 2007 (NCT00947765)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • BloodSupplementation

    Blood supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • autologous blood
  • autologous blood transfusion

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05775211N/AMar 13, 2023Nadezhda Women's Health Hospital
NCT06236178N/AJan 1, 2023Istanbul University
NCT05589285N/AJan 1, 2023Sultan Qaboos University
NCT05401162N/AApr 15, 2022Chongqing Medical University
NCT05401175N/AApr 13, 2022Chongqing Medical University
NCT04383756Early Phase 1 (Phase 1)Jul 31, 2020Vanderbilt University
NCT03548766Phase 3Oct 31, 2018Anti-Doping Lab Qatar, Hamad Medical Corporation, Laboratorio Antidoping FMSI, Sidra Medical and Research Center, World Anti-doping Agency
NCT03204357N/ASep 30, 2018University of Colorado, Denver
NCT03659955N/ANov 7, 2017Government of Scotland, NHS Lanarkshire, NHS Research Scotland
NCT02519816Phase 2Mar 31, 2016University of Montreal
NCT02352012N/AFeb 28, 2015Changhai Hospital, China Meitan General Hospital, Guangzhou Medical University, Micro-Tech (Nanjing) Co., Ltd., People's Liberation Army of China
NCT02546089N/AOct 31, 2014University of Leicester
NCT02423135N/AOct 1, 2014Swiss Laboratory for Doping Analyses, University of Lausanne
NCT02089828N/AMar 31, 2014Fudan University
NCT02747615Phase 4Aug 1, 2010Ain Shams University
NCT01528267Phase 2Nov 30, 2009University of London
NCT00583466Phase 2May 1, 2007Johns Hopkins University
NCT00947765Phase 2/Phase 3 (Phase 3)Jan 1, 2007Dojode, Chetan M., MBBS, MS, Jawaharlal Nehru Medical College
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chongqing Medical UniversityAcademic/Hospital2212022
Ain Shams UniversityAcademic/Hospital1112010
Anti-Doping Lab QatarAcademic/Hospital1012018
Changhai HospitalAcademic/Hospital1012015
China Meitan General HospitalAcademic/Hospital1012015
Dojode, Chetan M., MBBS, MSAcademic/Hospital1112007
Fudan UniversityAcademic/Hospital1112014
Government of ScotlandGovernment1012017
Guangzhou Medical UniversityAcademic/Hospital1012015
Hamad Medical CorporationFor profit1112018
Istanbul UniversityAcademic/Hospital1112023
Jawaharlal Nehru Medical CollegeAcademic/Hospital1012007
Johns Hopkins UniversityAcademic/Hospital1112007
Laboratorio Antidoping FMSIAcademic/Hospital1012018
Micro-Tech (Nanjing) Co., Ltd.For profit1012015
Nadezhda Women's Health HospitalAcademic/Hospital1112023
NHS LanarkshireAcademic/Hospital1112017
NHS Research ScotlandAcademic/Hospital1012017
People's Liberation Army of ChinaGovernment1112015
Sidra Medical and Research CenterAcademic/Hospital1012018
29 organizations
Page 1 / 2